Ginnie (Hsiu Chiung) Yang
About Ginnie (Hsiu Chiung) Yang
Ginnie (Hsiu Chiung) Yang is the Senior Vice President of Translational Medicine at Wave Life Sciences, where she leverages her expertise in machine learning and artificial intelligence to enhance digital medicine initiatives. With extensive experience in drug discovery across various modalities, she has held leadership positions at notable companies including AstraZeneca, Bayer, Novo Nordisk, and Eli Lilly.
Current Role at Wave Life Sciences
Ginnie Yang serves as the Senior Vice President of Translational Medicine at Wave Life Sciences, a position she has held since 2023. Based in Cambridge, Massachusetts, she focuses on advancing translational medicine initiatives. Her role involves leveraging her extensive experience in drug discovery and development to enhance the company's research efforts.
Previous Experience at Bayer
Prior to her current role, Ginnie Yang worked at Bayer as Vice President from 2022 to 2023 in Wuppertal, North Rhine-Westphalia, Germany. She had previously held the same title at Bayer from 2021 to 2022 in Berlin, Germany. Her work at Bayer involved utilizing machine learning and artificial intelligence to drive digital medicine initiatives.
Career Background in Pharmaceutical Industry
Ginnie Yang has a diverse background in the pharmaceutical industry, having held various roles at notable companies. She worked at AstraZeneca as Director from 2016 to 2020 in Sweden and as Science Lead for the Late Stage Diabetes Portfolio during the same period. Additionally, she served as Senior Director at Novo Nordisk from 2020 to 2021 in Denmark and as Research Advisor at Eli Lilly and Company from 2008 to 2016 in Indianapolis.
Educational Qualifications
Ginnie Yang completed her studies at The Ohio State University College of Medicine, earning her degree from 1992 to 1996. She also pursued postdoctoral research in Chemistry and Biochemistry at the University of California, San Diego from 1996 to 1998. Her educational background provides a strong foundation for her work in translational medicine and drug discovery.
Expertise in Drug Discovery and Development
Ginnie Yang has a proven track record as a drug hunter, working across various modalities including small molecules, peptides, antibodies, PROTACs, and X-Chem technologies. She possesses expertise in implementing precision medicine strategies in metabolic, cardiovascular, inflammatory diseases, pain, and Alzheimer's disease. Her comprehensive background in international regulatory affairs supports the global development and approval of new therapies.